$SHPH
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Christopher Robert Cooper
CEO
9
Employees
$3.70
Current Price
$2.07M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 1 | 2 | $30,212.49 | 8,997 | 1:16.71 |
| Sells | 1 | 5 | $504,831.53 | 121,282 | ||
| 2 months | Buys | 1 | 6 | $181,764.22 | 53,398 | 1:2.78 |
| Sells | 1 | 5 | $504,831.53 | 121,282 | ||
| 3 months | Buys | 1 | 6 | $181,764.22 | 53,398 | 1:2.78 |
| Sells | 1 | 5 | $504,831.53 | 121,282 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | HRT FINANCIAL LP 10% Owner | Sale | 1,033 | $4.67 | $4,824.11 | View Details |
| Jul 14, 2026 | HRT FINANCIAL LP 10% Owner | Sale | 82,116 | $4.48 | $367,879.68 | View Details |
| Jul 9, 2026 | HRT FINANCIAL LP 10% Owner | Purchase | 8,266 | $3.38 | $27,939.08 | View Details |
| Jul 10, 2026 | HRT FINANCIAL LP 10% Owner | Purchase | 731 | $3.11 | $2,273.41 | View Details |
| Jul 7, 2026 | HRT FINANCIAL LP 10% Owner | Sale | 10,580 | $3.33 | $35,231.40 | View Details |
| Jul 8, 2026 | HRT FINANCIAL LP 10% Owner | Sale | 18,531 | $3.52 | $65,229.12 | View Details |
| Jul 2, 2026 | HRT FINANCIAL LP 10% Owner | Purchase | 7,851 | $3.54 | $27,792.54 | View Details |
| Jul 6, 2026 | HRT FINANCIAL LP 10% Owner | Sale | 9,022 | $3.51 | $31,667.22 | View Details |
| Jul 1, 2026 | HRT FINANCIAL LP 10% Owner | Purchase | 3,959 | $3.30 | $13,064.70 | View Details |
| Jun 29, 2026 | HRT FINANCIAL LP 10% Owner | Purchase | 25,836 | $3.44 | $88,875.84 | View Details |
| Jun 30, 2026 | HRT FINANCIAL LP 10% Owner | Purchase | 6,755 | $3.23 | $21,818.65 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies:
$KUST โ KUSTOM ENTERTAINMENT, INC.via HRT FINANCIAL LP$BINI โ Bollinger Innovations, Inc.via HRT FINANCIAL LP$WHLR โ Wheeler Real Estate Investment Trust, Inc.via HRT FINANCIAL LP$GDC โ GD Culture Group Ltdvia HRT FINANCIAL LP$BJDX โ Bluejay Diagnostics, Inc.via HRT FINANCIAL LP$ADTX โ Aditxt, Inc.via HRT FINANCIAL LP$ZNB โ Zeta Network Groupvia HRT FINANCIAL LP$NCRA โ NOCERA, INC.via HRT FINANCIAL LP$FLJ โ FLJ Group Limitedvia HRT FINANCIAL LP$ONCO โ Onconetix, Inc.via HRT FINANCIAL LP